Abstract
Tumoral high-endothelial venule (TU-HEV) formation after antiangiogenic immunotherapy generates niches for progenitor T-cell expansion and differentiation into effector T cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
